Cowen Raises Price Target on Nike (NKE) to $140 Following 1Q EPS Growth
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Nike (NKE) PT Raised to $140 at Nomura Securities
September 25, 2015 10:32 AM EDTNomura Securities analyst Robert Drbul reiterated a Buy rating and raised his price target on Nike (NYSE: NKE) to $140.00 (from $125.00) following strong results after the close.
Drbul commented, "Nike reported exceptional first quarter results, incl. a 5.4% revenue increase (+14% in CC), above our +LSD... More
UBS Raises Price Target on Nike (NKE) to $137 Following 1Q16
September 25, 2015 10:23 AM EDTUBS reiterated a Buy rating on Nike (NYSE: NKE), and raised the price target to $137.00 (from $128.00), following the company's 1Q16 earnings results.
Analyst Michael Binetti commented, "Nike's global futures accelerated significantly to +17% ex-FX from +13% in F4Qvs our above-Consensus +14% est (Street was at... More
Canaccord Genuity Raises Price Target on Nike (NKE) to $119 Following 15c EPS Beat
September 25, 2015 10:12 AM EDTCanaccord Genuity reiterated a Hold rating on Nike (NYSE: NKE), and raised the price target to $119.00 (from $109.00), following the company's 1Q16 earnings results. NKE reported EPS of $1.34 vs. $1.19 consensus estimate.
Analyst Camilo Lyon commented, "NKE reported stellar FQ1 EPS of $1.34 vs. our $1.19 consensus... More
Sterne Agee CRT Upgrades Nike (NKE) to Buy Following 1Q16 EPS Beat
September 25, 2015 8:28 AM EDTSterne Agee CRT upgraded Nike (NYSE: NKE) from Neutral to Buy with a price target of $150.00 following the company's 1Q16 results. EPS came in at $1.34 versus consensus estimate of $1.19.
Analyst Sam Poser commented, "Nike executes its mission of bringing "inspiration and... More
Piper Jaffray Raises Price target on Nike (NKE) Following 15c EPS BEat
September 25, 2015 7:35 AM EDTPiper Jaffray reiterated an Overweight rating on Nike (NYSE: NKE), and raised the price target to $130.00 (from $120.00), following the company's 1Q16 earnings results. EPS of $1.34 was well ahead of the Street's $1.19 estimate.
Analyst Erinn Murphy commented, "We are reiterating our Overweight rating and... More
FBR Capital Raises Price Target on Nike (NKE) to $120 Following 1Q16 EPS Beat
September 25, 2015 6:55 AM EDTFBR Capital reiterated a Market Perform rating on Nike (NYSE: NKE), and raised the price target to $120.00 (from $109.00) following the company's 1Q16 earnings report. NKE reported a solid EPS beat of $1.34 versus consensus of $1.19.
Analyst Susan Anderson commented, "NKE reported a solid F1Q16 EPS beat of $1.34 versus FBR/consensus of $1.18/... More
Nike (NKE) PT Raised to $136 at Jefferies
September 25, 2015 6:53 AM EDTJefferies analyst Edward Plank reiterated a Buy rating and bumped his price target on Nike (NYSE: NKE) to $136.00 (from $128.00) following strong Q1 results.
Plank commented, "Nike exceeded expectations on nearly all fronts in F1Q, even in China and Europe, where market fears were... More
After Hours Stocks Movers 09/24: (BLPH) (NKE) (MRVL) Higher; (INAP) (PIR) (BBBY) (more...)
September 24, 2015 5:53 PM EDTBellerophon Therapeutics, Inc. (Nasdaq: BLPH) 61% HIGHER; announced positive data from an interim analysis of the Company's Phase 2 long-term extension study of INOpulse for the treatment of Pulmonary Arterial Hypertension (PAH) (Part 2 of the Company's Phase 2 trial). The data reinforce the results from Part 1 of the Phase 2 trial and indicate a sustainability of benefit to PAH patients who received INOpulse therapy. Bellerophon also reported today that the U.S. Food and Drug Administration (FDA) has issued a Special Protocol Assessment (SPA) for the Company's Phase 3 PAH program for... More
Market Wrap: Fed Rate Hike May Happen in '15; Durable Orders Slip in August; Caterpillar Trims Outlook, Plans Cost Cuts
September 24, 2015 5:18 PM EDTMarket wrap for September 24th
End of the Day: S&P 500 down 6.5 to 1,932.24; Dow Jones down 16,201.32 to 78.6; Nasdaq down 18.3 to 4,734.48
Market Brief: U.S. markets slipped lower for a second session as worries about issues in the automotive sector hampered European markets amid the Volkswagen emissions scandal.
Caterpillar announced cost reduction plans, which includes substantial job cuts, and trimmed its outlook.
Fed chair Yellen sees a rate hike happening this year.
New home sales came in better than... More
Nike (NKE) Peers Trade Higher in Sympathy Following Q1 Beat (UA) (FINL) (FL) (SKX)
September 24, 2015 4:59 PM EDTNike (NYSE: NKE) peers traded higher after-hours Thursday after it reported stronger than expected Q1 results
Related names include:
Finish Line (NASDAQ: FINL)Under Armour (NYSE: UA)Skechers USA (NYSE: SKX)Foot Locker (NYSE: FL)... More
Nike sprints ahead as China sales defy economic slowdown
September 24, 2015 4:25 PM EDTBy Ramkumar Iyer and Adam Jourdan
BENGALURU/SHANGHAI (Reuters) - Nike Inc's (NYSE: NKE) first-quarter profits outpaced expectations as surprisingly steep China growth boosted the world's largest sportswear maker, despite fears of a slowdown in the world's second-biggest economy.
The U.S. firm's global profit rose 23 percent in the three months to Aug. 31 as sales in Greater China jumped by nearly a third and earnings before interest and taxes (EBIT) soared 51 percent. Nike described the China results as "amazing".
Nike's strong China showing bucks a wider trend of... More
Nike (NKE) Tops Q1 EPS by 15c; Futures Orders up 17%, ex. FX
September 24, 2015 4:16 PM EDTNike (NYSE: NKE) reported Q1 EPS of $1.34, $0.15 better than the analyst estimate of $1.19. Revenue for the quarter came in at $8.4 billion versus the consensus estimate of $8.22 billion.
Fiscal 2016 is off to a great start, said Mark Parker, President and CEO of NIKE, Inc.... More
Nike (NKE) Trends Higher Ahead of Q1 Report
September 24, 2015 3:01 PM EDTNIKE, Inc. (NYSE: NKE) is trending higher late Thursday heading into its Q1'16 report, which is expected out after markets close.
Consensus estimates call for EPS of $1.19 with revenue of $8.22 billion, from EPS of $1.09 and revenue of $7.98 billion posted in the... More
Trading Radar for 9/24: Nike (NKE), KB Home (KBH), Bed Bath & Beyond (BBBY), Scholastic (SCHL) Report
September 23, 2015 2:20 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EDT
Earnings:
KB Home (NYSE:... More
Piper Jaffray Remains Bullish on Nike (NKE) Ahead of 1Q16 Results
September 23, 2015 7:51 AM EDTPiper Jaffray reiterated an Overweight rating and $120.00 price target on Nike (NYSE: NKE) ahead of the company's 1Q16 earnings results. NKE is scheduled to report its results after market closes on September 24th.
Analyst Erinn Murphy commented, "We are maintaining... More

